Perioperative management : According to 2024 multi-society guidance, most patients can continue GLP-1 receptor agonists perioperatively, though individualized risk assessment is recommended, particularly for major gastrointestinal surgery or procedures with high aspiration risk
Post-Treatment Care: The IV drip session will end, your arm will be free of the catheter, and you can get back to your regular activities
Wegovy (Semaglutide) Injection is an FDA-approved weight loss injection used to help you lose weight, reduce hunger, and feel full longer
However, New Jersey Bariatric Center's approach is led by bariatric physicians, doctors who specialize in weight loss and obesity medicine
There are a few possible explanations
Two combination therapies of basal insulin and GLP-1RA are currently available: insulin degludec/liraglutide (IDegLira) and insulin glargine/lixisenatide (IGlarLixi), both for once-daily administration [6]